Office of Public Affairs | Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls

The Office of Public Affairs for the Justice Department announced that FDA-approved marijuana products and marijuana-containing products holding a qualifying state-issued license will be classified as Schedule III substances. This significant change aims to bolster medical research on marijuana, facilitating scientific inquiry while enforcing strict federal regulations. By moving these products to Schedule III, the government acknowledges their potential medical benefits while ensuring that they remain controlled substances. This regulatory shift is intended to strike a balance between promoting public health through research advancements and maintaining the necessary safeguards to prevent misuse. This move reflects an evolving approach to cannabis that acknowledges its medicinal value, all while upholding federal oversight.

For more details and the full reference, visit the source link below:

Read the complete article here: https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana